Get started
Author

Tripti Arora

ORCID: 0000-0002-9400-6803
Observed ORCID: 0000-0002-9400-6803
OpenAlex ID: A5004352327
International Regulatory Frameworks and Best Practices in Management of POPs
2023 · Piyush Mohapatra, Emmy Nøklebye, et al. · Emerging contaminants and associated treatment technologies · 12
Docking Studies of Potent Xanthine Oxidase Inhibitors-Molecules Patented and Published from 2011-2020
2022 · Tripti Arora, Ketki Rani · Oriental Journal Of Chemistry · 3
PDF
Environmental and Health Impacts
2023 · Tripti Arora, Piyush Mohapatra, et al. · Emerging contaminants and associated treatment technologies · 2
Unlocking Therapeutic Potential: Molecular Docking Insights into Aurora Kinase A Inhibitors Patented and Published from 2011-2020 for Innovative Anticancer Drug Design
2024 · Ketki Rani, Avijit Mazumder, et al. · Letters in Drug Design & Discovery · 1
A Systematic Review on Association between Dietary Acrylamide and Cancer Risk
2021 · Suman Rohilla, Tripti Arora · Journal of Pharmaceutical Research International · 1
From Bench to Algorithm: A Five-year Review on Targeting HER2, EGFR, and VEGFR in Breast Cancer
2026 · Kajal Kaushik, Sonu Yadav, et al. · Current Signal Transduction Therapy
Rational Design and Computational Evaluation of Sulfonamide-Quinoline Derivatives as Multi-Targeted Anti-Cancer Agents
2025 · Sonu Sonu, Kajal Kaushik, et al. · Oriental Journal Of Chemistry
Works count: 7
Citation count: 19
H-index: 2
I10-index: 1
Year
Topic
Type